83647-40-9

Basic information

• Product Name: 3- BROMO-2-METHYL- BENZALDEHYDE
• Synonyms: 3- BROMO-2-METHYL- BENZALDEHYDE;3-broMo-2-tolualdehyde;3-Bromo-2-methylbenzaldehyde 97%;3-Bromo-o-tolualdehyde, 2-Bromo-6-formyltoluene;3-Bromo-2-methylbenzaldehyde97%
• CAS NO: 83647-40-9
• Molecular Formula: C₈H₇BrO
• Molecular Weight: 199.04458
• EINECS: 200-258-5
• Mol File: 83647-40-9.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 255.3±20.0 °C(Predicted)
• Appearance: /
• Density: 1.490±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3- BROMO-2-METHYL- BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3- BROMO-2-METHYL- BENZALDEHYDE(83647-40-9)
• EPA Substance Registry System: 3- BROMO-2-METHYL- BENZALDEHYDE(83647-40-9)

Safety Data

• Hazardous Substances Data: 83647-40-9(Hazardous Substances Data)

Usage

General Description

3-Bromo-2-methyl-benzaldehyde is a chemical compound with the molecular formula C8H7BrO. It is a white to yellow crystalline solid that is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and organic compounds. Its chemical structure consists of a benzene ring with a methyl group and a bromine atom attached to it, as well as an aldehyde functional group. 3- BROMO-2-METHYL- BENZALDEHYDE is known for its strong and characteristic odor, and it is also used in the production of fragrances and flavoring agents. Additionally, 3-Bromo-2-methyl-benzaldehyde has been studied for its potential biological activities, including its antibacterial and antifungal properties.

Upstream product

• 529-20-4 2-methylphenyl aldehyde 
• 76006-33-2 3-bromo-2-methylbenzoic acid 
• 69321-60-4 2,6-dibromotoluene 
• 68-12-2 N,N-dimethyl-formamide 
• 83647-43-2 3-bromo-2-methylbenzyl alcohol 
• 631909-08-5 3-bromo-N-methoxy-2, N-dimethylbenzamide 

Downstream Products

• 1344997-83-6 (E)-2-(3-bromo-2-methylphenyl)ethenyl methyl ether 
• 1344996-73-1 1-{2-[3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-2-methylphenyl]ethyl}-4-piperidinecarboxylic acid 
• 1344996-93-5 1-{2-[3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-methylphenyl]ethyl}-4-piperidinecarboxylic acid 
• 1344997-86-9 [3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-2-methylphenyl]acetaldehyde 
• 1344997-84-7 4,4,5,5-tetramethyl-2-{2-methyl-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,3,2-dioxaborolane 
• 1344997-85-8 2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-5-{2-methyl-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,3,4-thiadiazole 
• 1344997-92-7 5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-3-{2-methyl-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,2,4-thiadiazole 
• 1344997-93-8 [3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-methylphenyl]acetaldehyde 
• 50536-58-8 5-bromo-4-methyl-1H-indole-2-carboxylic acid 
• 1857296-39-9 methyl 5-bromo-4-methyl-1H-indole-2-carboxylate 
• 631909-09-6 1-bromo-3-dimethoxymethyl-2-methyl-benzene 
• 859518-20-0 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 

Relevant articles and documents

Heterocyclic substituted biphenyl compound as well as preparation method and application thereof

The invention discloses a heterocyclic substituted biphenyl compound as well as a preparation method and application thereof. According to the present invention, the compound can block the PD-1/PD-L1 signal pathway, and can be used as the immune checkpoint PD-1/PD-L1 small molecule inhibitor; and according to the compound disclosed by the invention, the metabolic stability is improved while the high binding rate with PD-L1 protein is maintained. A hydrophilic group is introduced to a heterocyclic ring, and the PD-1/PD-L1 inhibitory activity is improved.

IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF

Provided are compounds of formula I, pharmaceutical compositions thereof, and methods of using the compounds as immunomodulators. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

METHODS OF PROMOTING BETA CELL PROLIFERATION

The present disclosure provides methods of promoting proliferation of a pancreatic cell. The methods are useful for the treatment of diabetes and other diseases characterized by impaired glucose tolerance.